机译:肾移植受者患者慢性丙型肝炎病毒感染治疗肾移植受者的慢性丙型肝炎病毒感染
Zhejiang Univ Affiliated Hosp 1 Coll Med Kidney Dis Ctr Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Kidney Dis Ctr Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Kidney Dis Ctr Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Kidney Dis Ctr Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Kidney Dis Ctr Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Kidney Dis Ctr Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Kidney Dis Ctr Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Kidney Dis Ctr Hangzhou Zhejiang Peoples R China;
daclatasvir; direct-acting antivirals; hepatitis C virus; kidney transplant; sofosbuvir;
机译:肾移植受者患者慢性丙型肝炎病毒感染治疗肾移植受者的慢性丙型肝炎病毒感染
机译:用龙肝炎病毒基因型1或4感染治疗肾移植受体12或24周的雷普斯vir-sofosbuvir治疗12或24周
机译:在患有慢性乙型肝炎病毒感染的肾移植受者中成功撤消抗病毒治疗。
机译:聚类分析评估混合感染(肺结核,慢性病毒性肝炎,HIV感染)和海洛因成瘾患者临床和形态学参数之间的相互依赖性
机译:用于治疗慢性乙型肝炎病毒感染的病毒疫苗载体。
机译:索非布韦和达卡他韦在治疗丙型肝炎病毒感染的肾移植患者中的疗效和安全性
机译:Sofosbuvir和Daclatasvir治疗肾移植受试者肝炎病毒感染的疗效和安全性